Roman Tremmel

14PUBLICATIONS
86CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersNanoelectronics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 11, 2025
Clinical Implementation of Pharmacogenomics and Drug-Drug Interaction Screening in a German Academic Teaching Hospital and Outpatient Follow-Up.

Roman Tremmel, Filippa Schreeck, Simon Jaeger

|Oct 02, 2025
Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II Trial.

Thomas E Mürdter, Werner Schroth, Matthew P Goetz

|Jun 24, 2025
Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE Study.

Henk-Jan Guchelaar, Cathelijne H van der Wouden, Lisanne E N Manson

|Nov 14, 2024
PharmFreq: a comprehensive atlas of ethnogeographic allelic variation in clinically important pharmacogenes.

Roman Tremmel, Yitian Zhou, Mahamadou D Camara

|Oct 15, 2024
Innovation in cancer pharmacotherapy through integrative consideration of germline and tumor genomes.

Roman Tremmel, Daniel Hübschmann, Elke Schaeffeler

|Nov 16, 2023
Nutrimetric Validation of Solanidine as Dietary-Derived CYP2D6 Activity Marker In Vivo.

Julian Peter Müller, Jens Sarömba, Patrick Ziegler

Pageof 3